CastleKnight Management LP Purchases Shares of 99,900 Mirion Technologies, Inc. (NYSE:MIR)

CastleKnight Management LP bought a new stake in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 99,900 shares of the company's stock, valued at approximately $1,743,000.

Several other institutional investors have also recently made changes to their positions in the business. US Bancorp DE raised its stake in shares of Mirion Technologies by 3,248.7% in the fourth quarter. US Bancorp DE now owns 6,262 shares of the company's stock valued at $109,000 after acquiring an additional 6,075 shares during the period. Tower Research Capital LLC TRC raised its holdings in shares of Mirion Technologies by 162.9% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock worth $116,000 after purchasing an additional 4,120 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new position in shares of Mirion Technologies in the 4th quarter valued at $120,000. KBC Group NV increased its position in shares of Mirion Technologies by 39.2% in the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock valued at $140,000 after buying an additional 2,254 shares in the last quarter. Finally, Corient Private Wealth LLC acquired a new stake in Mirion Technologies in the 4th quarter worth about $187,000. Hedge funds and other institutional investors own 78.51% of the company's stock.

Analyst Ratings Changes

MIR has been the topic of several recent research reports. B. Riley lowered their target price on Mirion Technologies from $19.00 to $17.00 and set a "buy" rating on the stock in a report on Wednesday, April 16th. Robert W. Baird dropped their target price on Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, April 4th. Finally, Citigroup reduced their price target on Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, Mirion Technologies has an average rating of "Buy" and a consensus target price of $18.75.

Mirion Technologies Trading Up 1.7 %

Shares of NYSE:MIR traded up $0.28 during midday trading on Friday, reaching $16.41. 947,349 shares of the company's stock were exchanged, compared to its average volume of 1,689,368. The firm's 50 day simple moving average is $14.61 and its two-hundred day simple moving average is $15.74. Mirion Technologies, Inc. has a fifty-two week low of $9.11 and a fifty-two week high of $18.81. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.16 and a quick ratio of 1.55. The stock has a market cap of $3.81 billion, a price-to-earnings ratio of -86.37 and a beta of 0.74.

Mirion Technologies (NYSE:MIR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The firm had revenue of $202.00 million during the quarter, compared to analysts' expectations of $199.34 million. During the same quarter last year, the company posted $0.06 EPS. The firm's quarterly revenue was up 4.9% on a year-over-year basis. As a group, sell-side analysts forecast that Mirion Technologies, Inc. will post 0.39 EPS for the current fiscal year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.